High Gene Therapy Costs Trigger Call for New Payment Models – Genetic Engineering & Biotechnology News
Bloomberg |
High Gene Therapy Costs Trigger Call for New Payment Models
Genetic Engineering & Biotechnology News The six-figure prices of new gene therapies will require payers, pharma companies, policymakers, and pharmacy benefit managers (PBMs) to develop new payment models that ensure patient access while reflecting the value delivered by the new treatments … Novartis’s $475000 Price on Cancer Therapy Meets ResistanceBloomberg |
OncLive |
Patient Selection for Upfront Immunotherapy in NSCLC
OncLive Everett Vokes, MD: You mentioned a number of trials that are very information to this. Naiyer, I wonder if you could just go over those a little bit more in detail? When should pembrolizumab, alone, be used? There’s an alternative of combining … |
|
Why CAR–T Therapies Don’t Work for Everyone Yet
Genetic Engineering & Biotechnology News The newest treatment categorized as a living drug is called Kymriah (tisagenlecleucel). Developed by Novartis, it is the first FDA-approved chimeric antigen receptor T–cell (CAR-T) therapy, which has helped patients battle against a blood cancer called … |
Nature.com |
CRISPR Used for First Time to Study Gene Function in Human Embryos
Genetic Engineering & Biotechnology News Scientists report the first use of CRISPR/Cas9 genome editing to study gene function in developing human preimplantation embryos. The U.K.-based team, working with colleagues in South Korea, applied the CRISPR/Cas9 system to target the POU5F1 gene, … CRISPR used to peer into human embryos’ first daysNature.com Researchers are Now Editing Genomes of Human EmbryosTIME CRISPR Used in Human Embryos to Probe Gene FunctionThe Scientist Futurism –IFLScience –MedlinePlus –NIH Stem Cell Information all 93 news articles » |
|
Mutations Making CRISPR Hyper-Accurate Discovered
Genetic Engineering & Biotechnology News The potential benefits of the CRISPR gene-editing system have been championed by a huge array of researchers, clinicians, and biotech companies. While the data in recent years supports that CRISPR/Cas9 is effective in altering genes to circumvent many … |
TheHealthSite |
Novel Labyrinth Chip Monitors Cancer Stem Cells in Clinical Trial
Genetic Engineering & Biotechnology News Researchers at the University of Michigan have developed a novel chip containing fluid channels that sends blood samples through a hydrodynamic maze to separate circulating tumor cells into an analytic stream. The chip is currently being tested in a … Stem cells transplant to treat cancer – everything that you need to knowTheHealthSite Do you want to know about “United States Stem Cell Cartilage Regeneration Market” 2017 – 2022? CAGR will be more …Medgadget (blog) Global Cancer Stem Cell Therapy Market 2017 – AVIVA BioSciences, Advanced Cell Diagnostics, Silicon BiosystemsNews of Columnist: Research News By Market.Biz Newshawk Time –MilTech –satPRnews (press release) all 19 news articles » |
|
Gene Immunotherapy Reverses Paralysis in Mouse Model of …
Genetic Engineering & Biotechnology News U.S. scientists have developed gene therapy that can stop the development of multiple sclerosis (MS) in a mouse model of the autoimmune disorder, and … |
|
Gene Immunotherapy Reverses Paralysis in Mouse Model of …
Genetic Engineering & Biotechnology News U.S. scientists have developed gene therapy that can stop the development of multiple sclerosis (MS) in a mouse model of the autoimmune disorder, and … |